Effects of TNF-α blocking on experimental periodontitis and type 2 diabetes in obese diabetic Zucker rats
(Journal of Clinical Periodontology; doi: 10.1111/jcpe.12442)
Morten Bay Grauballe, Jakob Appel Østergaard, Søren Schou, Allan Flyvbjerg, Palle Holmstrup
TNF-alpha is one of the signals involved in inflammation. Researchers investigated whether blocking it could reduce periodontal damage and metabolic problems in an experimental model combining obesity and diabetes.
Rats with a diabetes-like condition received an inflammation-blocking medicine before periodontitis was induced. Researchers compared bone measurements, insulin-related tests and kidney findings with untreated experimental groups.
Some insulin-resistance measurements and dental X-ray findings were more favourable with treatment. However, direct bone measurements did not show the same pattern, and glucose tolerance and urine protein leakage did not clearly improve. The results were therefore mixed rather than a consistent reversal of periodontal or metabolic disease.
This experiment does not establish that an inflammation-blocking medicine should be used for gum disease in people with diabetes. Treatment started before the induced disease, and the rat model does not reproduce all features of human type 2 diabetes. Differences between measurement methods also limit confidence. The study explores a possible pathway for future research, not a reason to change existing diabetes or dental treatment or seek this medicine for periodontal care.
The experimental drug was given before disease induction, rather than as routine treatment of established human disease. Animal and laboratory studies allow researchers to investigate processes that cannot easily be tested in people. However, experimentally induced diabetes or gum damage does not reproduce every aspect of human disease. The timing, exposure and biological responses may differ substantially. A promising effect in this setting needs further testing for both benefit and harm before it can inform patient treatment. This paper therefore helps explain a possible mechanism; it does not establish an effective human treatment or a safe dose of an experimental substance.
Read the full article Back to Research
Periodontitis is the 6th most prevalent condition globally
Periodontitis and diabetes are bidirectionally linked
Diabetic complications are increased if you have both diseases
Successful periodontal treatment can improve blood glucose control
Periodontitis is the 6th most prevalent condition globally
Periodontitis and diabetes are bidirectionally linked
Diabetic complications are increased if you have both diseases
Successful periodontal treatment can improve blood glucose control
